GSK and Save the Children today launched a $1 million Healthcare Innovation Award to identify and reward innovations in healthcare which have proven successful in reducing child deaths in developing countries
A 1 million dollar award to reward healthcare innovations and help reducing child deaths in developing countries. It’s the initiative launched by GSK and Save the Children to provide a platform for winning organisations to showcase their innovations and share information to enable others with an interest in improving healthcare to adapt and replicate successful interventions and create more positive change for children in their own country and beyond.
Organisations from across the developing world can nominate examples of innovative healthcare approaches they have discovered or implemented. These approaches must have resulted in tangible improvements to under-5 child survival rates, be sustainable and have the potential to be scaled-up and replicated.
Co-chaired by Sir Andrew Witty, CEO of GSK, and Justin Forsyth, CEO of Save the Children, the Judging Panel, made up of experts from the fields of public health, science and academia, will award $250,000 to the best healthcare innovation to further progress their work. An additional $750,000 will be made available for runners-up awards. While good progress has been made in recent years, worldwide 6.9 million children every year still die before their fifth birthday. Often these children are in the most remote and marginalised communities and in order to bring life-saving healthcare to these hardest to reach children, ambitious new ideas and approaches are needed. The GSK and Save the Children Healthcare Innovation Award aims to discover and encourage replication of the best and most innovative examples of healthcare to have the biggest impact for vulnerable children.